Pemberton James M, Liu Qian, Andrews David W
Biological Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada, M4N 3M5.
Department of Medical Biophysics, University of Toronto, Ontario, Canada.
Bio Protoc. 2019 Oct 20;9(20):e3401. doi: 10.21769/BioProtoc.3401.
This protocol was designed to quantitatively measure small-molecule displacement of proteins in live mammalian cells using fluorescence lifetime imaging microscopy-Förster resonance energy transfer (FLIM-FRET). Tumour cell survival is often dependent on anti-apoptotic proteins, which bind to and inhibit pro-apoptotic proteins, thus preventing apoptosis. Small-molecule inhibitors that selectively target these proteins (termed BH3-mimetics) are therefore a promising avenue for the treatment of several cancers. Previous techniques used to study the efficacy of these drugs often use truncated versions of both pro- and anti-apoptotic proteins, as they are membrane bound and hydrophobic in nature. As a result, the true efficacy of these drugs to displace full-length pro-apoptotic proteins in their native environment within a cell is poorly understood. This protocol describes FLIM-FRET methods to directly measure the displacement (or lack of displacement) of full-length Bcl-2 family proteins in live mammalian cells.
本方案旨在利用荧光寿命成像显微镜-福斯特共振能量转移(FLIM-FRET)对活的哺乳动物细胞中蛋白质的小分子置换进行定量测量。肿瘤细胞的存活通常依赖于抗凋亡蛋白,这些抗凋亡蛋白与促凋亡蛋白结合并抑制它们,从而防止细胞凋亡。因此,选择性靶向这些蛋白的小分子抑制剂(称为BH3模拟物)是治疗多种癌症的一个有前景的途径。以前用于研究这些药物疗效的技术通常使用促凋亡蛋白和抗凋亡蛋白的截短版本,因为它们本质上是膜结合的且具有疏水性。因此,对于这些药物在细胞内天然环境中置换全长促凋亡蛋白的真正疗效了解甚少。本方案描述了FLIM-FRET方法,用于直接测量活的哺乳动物细胞中全长Bcl-2家族蛋白的置换(或未置换)情况。